EMERSON ELECTRIC CO(EMR)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #553 of 2,879 stocksTOP 25%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
EMR Stock Analysis & AI Quality Score
AI stock analysis and institutional research for EMERSON ELECTRIC CO (EMR), a Technology sector company. 13F Pro's AI-powered ranking engine scores EMR at 65.9/100 on a 32-signal composite quality model, placing it at rank #553 of 2,879 stocks — the top 25% of the AI-ranked universe. EMR scores in the top quartile across revenue scale (92.1), profitability (79.3). Areas of concern include earnings quality (3.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 47.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), EMERSON ELECTRIC CO reports quarterly revenue of $4.6B, net income of $618.0M, an operating margin of 17.4%. Top institutional holders of EMR by reported 13-F value include BlackRock,, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. EMR trades on the NYSE exchange and files with the SEC under CIK 32604. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EMR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for EMERSON ELECTRIC CO directly from SEC EDGAR. EMERSON ELECTRIC CO's 13F Pro composite quality score has ranged between 8 and 76 since 2021, currently 65.9 — a stable long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q2 2026
$4.6B
Net Income
Q2 2026
$618.0M
Free Cash Flow
Q2 2026
$694.0M
Operating Margin
Q2 2026
17.4%
ROIC
Q2 2026
2.9%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+15.3% YoYNet Income
-85.1% YoYEPS (Diluted)
-85.0% YoYTotal Assets
+3.5% YoYTotal Debt
-5.4% YoYOp. Cash Flow
+423.1% YoY| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $17.49B +15.3% | $15.16B +813.6% | $1.66B -87.2% | $12.93B -23.0% | $16.79B -8.6% | $18.37B |
| Net Income | $1.97B -85.1% | $13.22B +309.1% | $3.23B +40.3% | $2.30B +17.2% | $1.97B -14.8% | $2.31B |
| EPS (Diluted) | $3.43 -85.0% | $22.88 +322.9% | $5.41 +41.6% | $3.82 +17.9% | $3.24 -12.7% | $3.71 |
| Total Assets | $44.25B +3.5% | $42.75B +19.8% | $35.67B +44.3% | $24.71B +8.0% | $22.88B +11.6% | $20.50B |
| Total Debt | $8.75B -5.4% | $9.25B -18.9% | $11.41B +58.4% | $7.20B -7.7% | $7.81B +25.2% | $6.24B |
| Operating Cash Flow | $3.33B +423.1% | $637.0M -78.2% | $2.92B -18.3% | $3.58B +16.0% | $3.08B +2.6% | $3.01B |
AI Insight: EMR Financial Trends
Revenue growth stalled and debt remains elevated despite margin recovery; operating cash flow volatility persists.
• Revenue essentially flat year-over-year: Q1 2025 at $4,433M vs. Q1 2026 at $4,562M (+2.9%), trailing Q3 2025 peak of $4,855M.
• Net income stabilized around $600M in recent quarters after $585M in Q4 2024, suggesting normalized profitability post-spike.
• Total debt elevated at $13,359M in Q1 2026, substantially above Q4 2024 trough of $7,623M; debt-to-equity ratio near 0.66x.
⚠ Operating cash flow volatile: $779M in Q1 2026 vs. $1,070M in Q2 2025; seasonal pattern unclear given Q4 2025 weakness at $699M.
⚠ Debt spike in Q1 2025 ($14,363M) not fully reversed; elevated leverage may constrain flexibility if revenue growth remains stalled.
AI Insight: EMR Ratio Trends
Operating margin expanded 490bp from Q2 2024 to Q1 2026, while leverage stabilized after a mid-2025 spike.
• OpMargin climbed from 12.6% (Q2 2024) to 17.4% (Q1 2026), a sustained improvement despite volatility in ROE and ROA.
• D/E peaked at 0.75 in Q1 2025, then declined to 0.66 by Q1 2026, reversing prior leverage creep.
• ROIC ranged 7.1%–11.0% across quarters, settling at 9.4% (Q1 2026), below the 11.0% peak in Q4 2024.
⚠ ROIC declined 160bp from Q4 2024 (11.0%) to Q1 2026 (9.4%), despite margin expansion—capital efficiency under pressure.
⚠ ROE and ROA remain choppy; Q1 2026 ROE of 12.2% trails Q3 2025 peak of 12.5%, signaling volatility.
Get alerted when EMR's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for EMERSON ELECTRIC CO including:
Top Institutional Holders of EMR
BlackRock, Inc.
$5.5B41,811,242 shVANGUARD CAPITAL MANAGEMENT LLC
$4.8B36,526,083 shSTATE STREET CORP
$3.6B27,274,540 shBANK OF AMERICA CORP /DE/
$2.6B19,941,844 shVANGUARD PORTFOLIO MANAGEMENT LLC
$1.7B13,096,286 shGEODE CAPITAL MANAGEMENT, LLC
$1.6B12,546,905 shMORGAN STANLEY
$1.5B11,650,062 shWELLS FARGO & COMPANY/MN
$1.3B9,964,935 shWELLINGTON MANAGEMENT GROUP LLP
$1.3B9,618,055 shFisher Asset Management, LLC
$1.1B8,480,019 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $5.5B | 41,811,242 |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.8B | 36,526,083 |
| STATE STREET CORP | $3.6B | 27,274,540 |
| BANK OF AMERICA CORP /DE/ | $2.6B | 19,941,844 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.7B | 13,096,286 |
| GEODE CAPITAL MANAGEMENT, LLC | $1.6B | 12,546,905 |
| MORGAN STANLEY | $1.5B | 11,650,062 |
| WELLS FARGO & COMPANY/MN | $1.3B | 9,964,935 |
| WELLINGTON MANAGEMENT GROUP LLP | $1.3B | 9,618,055 |
| Fisher Asset Management, LLC | $1.1B | 8,480,019 |
More Technology Companies
View all Technology →Put EMR on your watchlist
Track score changes the day EMERSON ELECTRIC CO files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is EMR a good stock to buy?
13F Pro's AI-powered analysis of EMERSON ELECTRIC CO (EMR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for EMR are available on the EMR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own EMR?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling EMR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of EMERSON ELECTRIC CO's investment landscape.